^99mTechnetium-Unithiol Complex, a New Pharmaceutical for Kidney Scintigraphy

Summary

The investigations were carried out with a newly syn-thesised, original ^99mTc-Unithiol complex (Unithiol-2,3-dimercaptopropansulphonate). It accumulates in the kidneys and enables their scintigraphic examination at 90—180 minutes after the administration. The study was performed on rats, rabbits and dogs. ^99mTc-Unithiol complex accumulation in rat kidneys was 34,9%, 44,5% and 67,8% of dose after 1, 2 and 3 h respectively.

Good reability of the scintigraphic picture of the kidneys in rabbits and dogs confirms the accumulative capability of the complex in these organs. It was found by means of ascending paper chromatography that the purity of the ^99mTc-Unithiol complex exceeded 90%.

• References

• 1 Baker R. J, Bellen J. C, Ronal P. M. Technetium-99m-Pyridoxylidenglutamate: a new hepatobiliary Radiopharmaceutical. I. Experimental aspects. J. Nucl. Med 1975; 16: 720-727.
• 2 Blaumonte N. Chlormerodrina use of mercury 197 and 203 labelled for kidneys scanning. Answer to the Atomic Energy Commission O. N. J. Nucl. Med 1968; 9: 206.
• 3 Borisow W. P, Zurawliew W. Z, Iwanow W. A, Sewerin S. Z. Nieottoznaja Pomoszcz pri ostrych pora-zenijach Radioaktiwnymi Wieszczestwami. Atomizdat. (Moskwa). 1968: 140
• 4 Graban W, Jakubowski W. The harmful effects preparations labelled with ²⁰³Hg used for clinical diagnosis. Pol. Przeg. Rad. Med. Nukl. XXXIV, 1975; 5: 595-598.
• 5 Halpern S, Tubis M, Endow J, Walsh C, Kunsa J, Zwicker B. ^99mTc-penicillamine-acetazolamide complex, a new renal scanning agent. J. Nucl. Med 1972; 13: 45-50.
• 6 Hambright P, McRae J, Valk P. E, Bearden A. J, Shipley B. Chemistry of technetium radiopharmaceuticals, I. Exploration of the tissue distribution and oxidation sate consequences of technetium (IV) in Tc-Sn-Gluconate and Tc-Sn-EHDP using carrier ^99mTc. J. Nucl. Med 1975; 16: 478-482.
• 7 Handmaker H, Young Bradford W, Lowestein J. M. Clinical Experience with ^99mTc-DMSA (Dimercapto-succinic acid) a new renal-imaging agent. J. Nucl. Med 1975; 16: 28.
• 8 Hecking E, Pfannenstiel P. Nierenszintigraphie mit ^99mTc-DTPA-Fe-Komplex. Urologe. 1973: 126-129.
• 9 Konikowski T, Glenn H. J, Haynie T. P, Jahns M. F. An intercomparison of radiopharmaceutical kidney kinetics in the mouse. Int. J. Nucl. Med. Biol 1975; 2: 59-65.
• 10 Lin T. H, Khentigan A, Winchell H. S. A 99mTC-chelate substitute for organradiomerciurial renal agents. J. Nucl. Med 1974; 15: 34-35.
• 11 McRae J, Barry A. C, Valk P. E. Renal scintigraphy using technetium stannous chloride gluconate. Aust. N. Z. J. Med. 1971: 291 published in New Chemicals GmbH. D-6072 Dreieichenhain. W.-Germany: Stannous Glucoheptonate Kit for use in the preparation of Technetium 99mTc for renal scanning, p. 12 (1975)
• 12 Nouel J. P, Renault H, Robert J, Bertrand A, Dubois D, Brunelle Ph. L’Ascorbate ferrous marque — Interet pour la scintigraphic renale. Nouv. Presse méd 1972; 1 (36) 2399.
• 13 Ogiński M, Kloczkowski K. Use of unithiol for reducing radioation hazard of renal scintigraphy with chlormerodrin ²⁰³Hg. I. Estimation of the urinary excretion of ²⁰³Hg. International Urol. Neph 1973; 5: 371-376.
• 14 Starshinova A. E. A study on the antiarrhythmic action of unithiol in an experimental. Medycyna (Moskwa). 1975: 168-170.
• 15 Richard W. A, Subramanian G, McAfee J. G, Blair R. J, Deaver Thomas F. Comparison of ^99mTc complexes for renal imaging. J. Nucl. Med 1975; 16: 357-367.
• 16 Woźniak L, Ogiński M, Karasek M, Piatek T. Histologische und histochemische Untersuchungen an Rattennieren nach Verabreichung von Chlormerodrin ²⁰³Hg und Unithiol. Fortschr. Röntgenstr 1973; 119: 603-609.